{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538926/DRR538926_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538924/DRR538924_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538922/DRR538922_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538916/DRR538916_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538920/DRR538920_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538918/DRR538918_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538919/DRR538919_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538917/DRR538917_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538925/DRR538925_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538923/DRR538923_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538915/DRR538915_subreads.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR538/DRR538921/DRR538921_subreads.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"strain":["Human Embryonic Kidney cells 293"],"center_name":["Brain research Institute, Niigata University"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJDB17735"],"scientific_name":["Homo sapiens"],"long_description":["We used 293 cells stably expressing one copy of wild-type TREX1 or 3' frameshift mutant TREX1 (RVCL TREX1) in a doxycycline (Dox)-inducible manner using the Flp-in expression system. Double-strand breaks (DSB) were induced by CRISPR/Cas9 in each cell line expressing exogenous TREX1, and the deletion status at the cut site after DSB repair was analyzed by long-read sequencing. Sequence analysis was performed by acquiring HiFi reads using the PacBio Revio/Sequel IIe. The target gene was human ACTB, which was amplified using a primer flanking the cut site. Sequencing analysis was performed on an amplicon of approximately 3800 bp. The sample groups consisted of four groups: Dox-untreated wild-type TREX1-expressing cells and RVCL-expressing cells as controls, and each cell line sample that was Dox-treated and expressed exogenous TREX1. Three biological replicates were obtained for each group and the total sequence data consisted of 12 samples."],"tag":["xref:EuropePMC:PMC11144269"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Homo sapiens strain:Human Embryonic Kidney cells 293","description":"Analysis of the effects of human wild-type TREX1 and 3' frameshift mutant TREX1 (RVCL TREX1) expression on CRISPR/Cas9-induced DSB repair.","dates":{"last_updated":"2025-09-24","first_public":"2024-03-30"},"accession":"PRJDB17735","cross_references":{"taxon":["9606"]}}